BREAKING: Texas judge suspends FDA approval of major abortion pill
U.S. District Judge Matthew Kacsmaryk ruled that the agency's decades-old approval of mifepristone, the first of two abortion-inducing drugs used to terminate a pregnancy through 10 weeks, should be suspended. The ruling gives the Biden administration a week to appeal to the U.S. Court of Appeals for the 5th Circuit.
The FDA has repeatedly said that the abortion medication is a safe and effective alternative to surgical abortions. The American Medical Association, American College of Obstetricians and Gynecologists, and other medical associations have said in a court filing that reversing mifepristone's approval would"cause profound and irreparable harm to patients across the country.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market
続きを読む »
FDA Forces the Only Drug for Preterm Births to Leave MarketThe only drug approved by the FDA to prevent preterm births will longer be available. The agency said it is withdrawing its approval for the drug Makena due to its ineffectiveness.
続きを読む »
FDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market.
続きを読む »
FDA forces unproven premature birth drug Makena off marketThe Food and Drug Administration on Thursday ordered the immediate market withdrawal of a drug intended to prevent premature births, which has remained available for years despite data showing it doesn’t help pregnant women.
続きを読む »
FDA pulls pre-term birth drug Makena and its generics from market after 12 yearsThe U.S. Food and Drug Administration said Thursday it has reached a final decision to fully withdraw approval of pre-term birth drug Makena and its...
続きを読む »
FDA yanks approval of Makena, only drug cleared to lower preterm birthThe Food and Drug Administration on Thursday revoked the approval of Makena, the latest — and probably last — chapter of a long-running saga involving the only drug cleared to reduce the risk of preterm birth.
続きを読む »